Allergen Research Corporation Obtains $17,000,000 New Funding

  • Feed Type
  • Date
    11/22/2013
  • Company Name
    Allergen Research Corporation
  • Mailing Address
    2000 Alameda De Las Pulgas San Mateo, CA 94403
  • Company Description
    Allergen Research Corporation (ARC) develops treatments to protect children with food allergies from the threatening consequences of accidental exposure.
  • Website
    http://www.allergenresearch.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company intends to use the funds to support its upcoming Phase 2b clinical trial to evaluate peanut allergy oral immunotherapy (OIT) with characterized peanut allergen (CPNA), as well as related development projects.
  • M&A Terms
  • Venture Investor
    Longitude Capital Management
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.